Bush launches Pink Ribbon Red Ribbon project in Zambia

NewsGuard 100/100 Score

"Zambian President Michael Sata on Friday told former U.S. president George W. Bush that the West should help fight the scourge of maternal deaths in sub-Saharan Africa," Agence France-Presse reports, adding, "Bush is in Zambia on the second stop of a three-nation trip aimed at promoting efforts to fight diseases like cancer, AIDS and malaria" (12/3). While in Zambia, "Bush and his wife ... launched a project ... to expand the availability of cervical cancer screening, treatment and breast care education," making the country "the first ... to become part of the Pink Ribbon Red Ribbon project," the Associated Press/Seattle Times writes (12/2).

"Pink Ribbon Red Ribbon is an innovative partnership between the George W. Bush Institute, [PEPFAR], Susan G. Komen for the Cure and [UNAIDS] that leverages public and private investments and existing health infrastructures to combat cervical and breast cancer, the two leading causes of cancer deaths among women in sub-Saharan Africa," according to a UNAIDS press release (12/2). "'What is needed is support from the developed world. It should be our priority to save human life in all places,' said Bush," Agence France-Presse writes (12/3).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer